Table 2 Agreement on treatment recommendation listed in top three choices for management of dentin hypersensitivity
Treatment Recommended | Product Listed in Top Three on Survey | Agreement Between Survey and Exam | Kappa |
|---|---|---|---|
n (%) | % (95% CI) | (95% CI) | |
Fluoride Products | 156 (91.2%) | 72.5% (65.2, 79.1) | 0.08 (−0.06, 0.22) |
Desensitizing OTC Potassium Nitrate Toothpaste | 150 (87.7%) | 73.1% (65.8, 79.6) | 0.26 (0.12, 0.41) |
Restorative Treatments | 54 (31.6%) | 70.8% (63.3, 77.5) | 0.21 (0.07, 0.36) |
Glutaraldehyde/HEMA Products | 41 (24.0%) | 77.8% (70.8, 83.8) | 0.19 (0.04, 0.34) |
Bonding Agents | 34 (19.9%) | 81.3% (74.6, 86.8) | 0.29 (0.11, 0.47) |
Advice | 26 (15.2%) | 60.8% (53.1, 68.2) | 0.00 (−0.13, 0.13) |
Other | 16 (9.4%) | 69.6% (62.1, 76.4) | 0.22 (0.09, 0.34) |
Oxalates | 8 (4.7%) | 91.8% (86.6, 95.5) | 0.18 (−0.08, 0.44) |
Sealants | 8 (4.7%) | 95.3% (91.0, 98.0) | 0.18 (−0.14, 0.51) |
No Treatment | 7 (4.1%) | 90.6% (85.3, 94.6) | 0.23 (−0.02, 0.48) |
Lasers | 2 (1.2%) | 100% (97.9, 100) | 1.0 (1.0, 1.0) |